Promoter holding
64.27%
CS
Caregroup Sight Solution - Due diligence report
A 360° intelligence report on Caregroup Sight Solution: trust score, financial health, credit view, compliance, directors, growth and distre…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Caregroup Sight Solution — 360° Intelligence Report
Generated from MCA filings & public records75/100
Trust Score
Low Risk
Caregroup Sight Solution is assessed as Low Risk with a Trust Score of 75/100. Caregroup Sight Solution is an active private limited indian non-government company incorporated in 2020, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 03 Oct 2026 from the latest processed filings. Caregroup Sight Solution Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
50/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A-).
Charges position: 3 open (72.25 cr) · 4 satisfied (61.27 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 6 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
Compliance Score: 50/100 Moderate
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2024 - filings overdue.
- Litigation present in 1 court forum(s).
- 4 auditor resignation(s) filed - latest: PARIKH AND MAJMUDAR on 2025-02-28.
- Delayed payments to MSME suppliers disclosed (1 disclosure(s)).
- 16 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| JAGRAT NATVAR DAVE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PURNIMA JAGRAT DAVE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KRUTI VINAYAKBHAI TRIVEDI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIPAN KUMAR DUGGAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJAY ARGAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MUNAVVAR HUSAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PURNIMA JAGRAT DAVE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Shrinali Harshit Patel | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Abhijit Bhagvat Patil | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Ketan Nagjibhai Kotharia | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 10 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
1 allotment(s) · 1 transfer(s)
| Group entity | Relationship | % held |
|---|---|---|
| Care4sight Pharma Private Limited | Subsidiary Company | 74.00% |
| Uk Implant Manufacturing Co. Ltd. | Subsidiary Company | 74.00% |
| Uk Implant Manufacturing Egypt Co. | Subsidiary Company | 74.00% |
Key managerial personnel: JAGRAT NATVAR DAVE (Managing Director) · PURNIMA JAGRAT DAVE (CEO) · KRUTI VINAYAKBHAI TRIVEDI (CFO) · PURNIMA JAGRAT DAVE (CEO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 70
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Asset base grew 24% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Profit declined two years in a row.
Statutory filings appear overdue.
Compliance score is weak (50/100).
3 open charge(s) registered - assets are encumbered.
4 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 28,320.00.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence64/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 72.25 cr already registered.
- Compliance gaps should be priced into terms.
Investor view84/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events05 Nov 2025
Director appointed
Abhijit Bhagvat Patil (Director)
Director appointed
Ketan Nagjibhai Kotharia (Director)
20 Jan 2025
Director ceased
PURNIMA JAGRAT DAVE
16 Jan 2025
Last AGM held
Annual general meeting
31 Mar 2024
Share transfer (FY 2024)
18000000.00000000 shares to Purnima Jagrat Dave
Latest balance sheet
Filed with ROC
13 Dec 2023
Charge satisfied
Others
29 Nov 2023
Charge satisfied
Others
24 Nov 2023
Charge satisfied
Others
01 Jun 2023
Director appointed
PURNIMA JAGRAT DAVE (CEO)
Director appointed
KRUTI VINAYAKBHAI TRIVEDI (CFO)
30 Sep 2022
Director ceased
VIPAN KUMAR DUGGAL
Director ceased
SANJAY ARGAL
Director ceased
KETAN NAGJIBHAI KOTHARIA
Director ceased
MUNAVVAR HUSAIN
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
10 active director(s) / partner(s); board looks stable and experienced.
16 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A- from Care.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| The Sleep Company | U24304MH2019PTC333446 | Jogeshwari West, Maharashtra, India |
| Manohar Lal Sarraf & Sons Jewellers | U36911DL2003PTC122428 | New Delhi, Delhi, India |
| Bpl Medical Technologies | U33110KA2012PTC067282 | Bangalore North, Karnataka, India |
| Agappe | U24239MH1998PLC115413 | Mumbai, Maharashtra, India |
| Vinayak Oil & Fats Private Limited | U51909WB1997PTC085696 | Howrah, West Bengal, India |
| Arl Infratech | U26932RJ1996PLC012146 | Jaipur, Rajasthan, India |
| Ts Tech Sun Rajasthan Private Limited | U34300DL2008PTC181194 | New Delhi, Delhi, India |
| Biorad Medisys | U33111MH2000PTC265335 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Caregroup Sight Solution before audits and certifications: compliance score 50/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Caregroup Sight Solution: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Caregroup Sight Solution - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Caregroup Sight Solution pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Caregroup Sight Solution - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Caregroup Sight Solution an active company?
Caregroup Sight Solution has MCA status “Active” with a compliance score of 50/100 (Moderate).
Is Caregroup Sight Solution financially healthy?
Caregroup Sight Solution has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Caregroup Sight Solution?
Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Caregroup Sight Solution?
See the directors and ownership sections above for board and shareholding detail. 10 active director(s) are on record.
Does Caregroup Sight Solution have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.
Is Caregroup Sight Solution up to date with its ROC filings?
Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 50/100 (Moderate).
Is it risky to lend to Caregroup Sight Solution?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
